Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proto-Oncogene Proteins c-bcl-2 | 79 | 2024 | 1434 | 10.980 |
Why?
|
Apoptosis | 110 | 2024 | 9718 | 6.570 |
Why?
|
Sulfonamides | 49 | 2024 | 1938 | 5.340 |
Why?
|
Mitochondria | 58 | 2022 | 3513 | 4.770 |
Why?
|
Apoptosis Regulatory Proteins | 24 | 2021 | 1157 | 3.110 |
Why?
|
Leukemia, Myeloid, Acute | 26 | 2024 | 3524 | 2.930 |
Why?
|
Proto-Oncogene Proteins | 38 | 2024 | 4552 | 2.810 |
Why?
|
Nitrophenols | 16 | 2014 | 172 | 2.420 |
Why?
|
Drug Resistance, Neoplasm | 40 | 2022 | 5170 | 2.160 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 11 | 2019 | 92 | 2.160 |
Why?
|
bcl-X Protein | 17 | 2023 | 411 | 2.010 |
Why?
|
Biphenyl Compounds | 16 | 2014 | 913 | 2.010 |
Why?
|
Antineoplastic Agents | 43 | 2024 | 13691 | 1.840 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 14 | 2023 | 1596 | 1.680 |
Why?
|
Neoplasms | 34 | 2023 | 21675 | 1.530 |
Why?
|
Cell Line, Tumor | 65 | 2024 | 16674 | 1.400 |
Why?
|
bcl-2-Associated X Protein | 10 | 2019 | 295 | 1.390 |
Why?
|
Peptide Fragments | 23 | 2024 | 5096 | 1.350 |
Why?
|
Thiophenes | 5 | 2021 | 589 | 1.240 |
Why?
|
Aniline Compounds | 9 | 2021 | 986 | 1.230 |
Why?
|
Molecular Targeted Therapy | 13 | 2019 | 2727 | 1.150 |
Why?
|
Genes, bcl-2 | 7 | 2021 | 122 | 1.140 |
Why?
|
Mitochondrial Membranes | 9 | 2021 | 174 | 1.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 18 | 2021 | 11524 | 1.020 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 6 | 2023 | 75 | 0.980 |
Why?
|
Cell Death | 8 | 2019 | 1705 | 0.960 |
Why?
|
Xenograft Model Antitumor Assays | 21 | 2021 | 3547 | 0.930 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2023 | 407 | 0.890 |
Why?
|
Pyrimidines | 8 | 2021 | 2945 | 0.870 |
Why?
|
Membrane Proteins | 15 | 2014 | 7880 | 0.830 |
Why?
|
Hematologic Neoplasms | 8 | 2022 | 1832 | 0.750 |
Why?
|
Signal Transduction | 28 | 2023 | 23398 | 0.700 |
Why?
|
Pharmaceutical Preparations | 3 | 2022 | 1070 | 0.680 |
Why?
|
Proto-Oncogene Proteins c-myc | 4 | 2021 | 988 | 0.660 |
Why?
|
Leukemia | 5 | 2020 | 1509 | 0.660 |
Why?
|
Small Molecule Libraries | 3 | 2019 | 718 | 0.650 |
Why?
|
Piperazines | 18 | 2021 | 2487 | 0.640 |
Why?
|
Neoplastic Stem Cells | 6 | 2018 | 1376 | 0.630 |
Why?
|
Neoplasms, Experimental | 4 | 2020 | 1272 | 0.630 |
Why?
|
Tumor Cells, Cultured | 19 | 2021 | 6311 | 0.620 |
Why?
|
Animals | 90 | 2024 | 168660 | 0.620 |
Why?
|
Azacitidine | 7 | 2024 | 347 | 0.610 |
Why?
|
Sports | 1 | 2024 | 688 | 0.610 |
Why?
|
Drug Design | 6 | 2018 | 1075 | 0.600 |
Why?
|
Humans | 176 | 2024 | 743811 | 0.590 |
Why?
|
Lymphoma, B-Cell | 2 | 2018 | 931 | 0.580 |
Why?
|
Mice | 63 | 2022 | 81154 | 0.550 |
Why?
|
Adaptive Immunity | 1 | 2021 | 715 | 0.550 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2023 | 8430 | 0.540 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 6 | 2021 | 1377 | 0.540 |
Why?
|
Neoplasm Proteins | 10 | 2019 | 3706 | 0.530 |
Why?
|
Military Personnel | 1 | 2024 | 1133 | 0.500 |
Why?
|
Protein Kinase Inhibitors | 12 | 2022 | 5532 | 0.500 |
Why?
|
Drug Synergism | 10 | 2021 | 1794 | 0.500 |
Why?
|
Cell Survival | 17 | 2018 | 5881 | 0.480 |
Why?
|
Cytochromes c | 7 | 2017 | 180 | 0.480 |
Why?
|
Tumor Suppressor Protein p53 | 6 | 2021 | 2944 | 0.480 |
Why?
|
Paclitaxel | 5 | 2020 | 1705 | 0.470 |
Why?
|
Gene Expression Regulation, Leukemic | 7 | 2020 | 651 | 0.470 |
Why?
|
Killer Cells, Natural | 2 | 2022 | 2131 | 0.460 |
Why?
|
Membrane Potential, Mitochondrial | 6 | 2016 | 298 | 0.440 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2019 | 1520 | 0.440 |
Why?
|
Antineoplastic Agents, Phytogenic | 3 | 2016 | 623 | 0.440 |
Why?
|
Peptides | 6 | 2018 | 4406 | 0.440 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2021 | 789 | 0.430 |
Why?
|
Breast Neoplasms | 13 | 2022 | 20827 | 0.430 |
Why?
|
Medical Oncology | 2 | 2021 | 2267 | 0.420 |
Why?
|
ras Proteins | 4 | 2022 | 1059 | 0.410 |
Why?
|
Lung Neoplasms | 8 | 2021 | 13112 | 0.400 |
Why?
|
Stromal Cells | 3 | 2013 | 1356 | 0.380 |
Why?
|
Flow Cytometry | 4 | 2016 | 5973 | 0.370 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2542 | 0.370 |
Why?
|
Drug Therapy | 1 | 2013 | 496 | 0.370 |
Why?
|
Multiple Myeloma | 7 | 2022 | 5185 | 0.360 |
Why?
|
Immunotherapy | 3 | 2022 | 4437 | 0.360 |
Why?
|
Etoposide | 3 | 2019 | 641 | 0.350 |
Why?
|
Protein Processing, Post-Translational | 4 | 2018 | 1986 | 0.340 |
Why?
|
Immunity, Innate | 1 | 2021 | 2961 | 0.340 |
Why?
|
Permeability | 4 | 2016 | 738 | 0.330 |
Why?
|
Protein Interaction Domains and Motifs | 4 | 2016 | 474 | 0.330 |
Why?
|
Mice, SCID | 9 | 2021 | 2718 | 0.320 |
Why?
|
Minor Histocompatibility Antigens | 5 | 2019 | 298 | 0.320 |
Why?
|
Drug Delivery Systems | 4 | 2019 | 2217 | 0.320 |
Why?
|
Models, Biological | 9 | 2016 | 9582 | 0.310 |
Why?
|
Epidermolysis Bullosa Simplex | 5 | 1994 | 13 | 0.310 |
Why?
|
Drug Screening Assays, Antitumor | 6 | 2018 | 729 | 0.300 |
Why?
|
fms-Like Tyrosine Kinase 3 | 2 | 2023 | 491 | 0.290 |
Why?
|
Estrogen Receptor alpha | 2 | 2021 | 577 | 0.290 |
Why?
|
Cytarabine | 2 | 2019 | 692 | 0.290 |
Why?
|
MAP Kinase Signaling System | 4 | 2022 | 1524 | 0.290 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2021 | 5230 | 0.280 |
Why?
|
Ovarian Neoplasms | 5 | 2019 | 4839 | 0.280 |
Why?
|
Receptors, Estrogen | 2 | 2021 | 2190 | 0.270 |
Why?
|
DNA Damage | 6 | 2020 | 2429 | 0.270 |
Why?
|
Thymus Gland | 2 | 2010 | 1266 | 0.270 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2016 | 222 | 0.270 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2021 | 890 | 0.270 |
Why?
|
Mitochondria, Liver | 1 | 2006 | 187 | 0.260 |
Why?
|
Reactive Oxygen Species | 1 | 2013 | 2077 | 0.260 |
Why?
|
Myeloproliferative Disorders | 3 | 2018 | 606 | 0.260 |
Why?
|
Cell Communication | 1 | 2012 | 1621 | 0.250 |
Why?
|
Granulocyte Precursor Cells | 2 | 2016 | 43 | 0.250 |
Why?
|
Lymphocytes | 2 | 2012 | 2615 | 0.250 |
Why?
|
Benzamides | 3 | 2017 | 1383 | 0.250 |
Why?
|
Cell Membrane Permeability | 4 | 2018 | 589 | 0.240 |
Why?
|
Urodela | 1 | 2024 | 17 | 0.240 |
Why?
|
Keratins | 5 | 1994 | 515 | 0.240 |
Why?
|
Mythology | 1 | 2024 | 15 | 0.240 |
Why?
|
Protein Binding | 9 | 2019 | 9377 | 0.240 |
Why?
|
Leukemia, Lymphoid | 1 | 2004 | 315 | 0.240 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2006 | 430 | 0.240 |
Why?
|
Mice, Inbred NOD | 9 | 2021 | 1876 | 0.230 |
Why?
|
Caspases | 3 | 2023 | 928 | 0.230 |
Why?
|
Growth Substances | 1 | 2006 | 784 | 0.230 |
Why?
|
Karyopherins | 2 | 2015 | 137 | 0.230 |
Why?
|
Oncogene Proteins | 1 | 2007 | 749 | 0.230 |
Why?
|
Smallpox | 1 | 2003 | 45 | 0.220 |
Why?
|
bcl-Associated Death Protein | 3 | 2014 | 107 | 0.220 |
Why?
|
Cell Proliferation | 16 | 2021 | 10477 | 0.220 |
Why?
|
Spheroids, Cellular | 2 | 2017 | 348 | 0.220 |
Why?
|
Cell Line | 10 | 2021 | 15993 | 0.210 |
Why?
|
Intermediate Filament Proteins | 2 | 1995 | 269 | 0.210 |
Why?
|
Bioterrorism | 1 | 2003 | 143 | 0.210 |
Why?
|
Immunoglobulin Variable Region | 1 | 2023 | 421 | 0.210 |
Why?
|
Disease Models, Animal | 10 | 2022 | 18027 | 0.210 |
Why?
|
Macrophages | 1 | 2017 | 5651 | 0.210 |
Why?
|
Culture Media, Conditioned | 1 | 2023 | 537 | 0.210 |
Why?
|
Female | 45 | 2022 | 380020 | 0.210 |
Why?
|
Mutation | 18 | 2022 | 29777 | 0.200 |
Why?
|
Confusion | 1 | 2024 | 275 | 0.200 |
Why?
|
Janus Kinase 2 | 2 | 2015 | 528 | 0.200 |
Why?
|
Organ Specificity | 3 | 2016 | 2008 | 0.200 |
Why?
|
Zebrafish Proteins | 1 | 2008 | 1005 | 0.200 |
Why?
|
Amino Acid Sequence | 11 | 2016 | 13809 | 0.200 |
Why?
|
Viral Proteins | 2 | 2007 | 1899 | 0.190 |
Why?
|
Thionucleotides | 2 | 2012 | 107 | 0.190 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2013 | 437 | 0.190 |
Why?
|
Immunoprecipitation | 4 | 2016 | 906 | 0.190 |
Why?
|
Interleukin-3 Receptor alpha Subunit | 1 | 2019 | 39 | 0.180 |
Why?
|
Hematopoietic Stem Cells | 3 | 2018 | 3389 | 0.180 |
Why?
|
Mitoxantrone | 1 | 2019 | 152 | 0.180 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2916 | 0.170 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2015 | 871 | 0.170 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 2019 | 34 | 0.170 |
Why?
|
Maximum Tolerated Dose | 2 | 2018 | 892 | 0.170 |
Why?
|
Inhibitory Concentration 50 | 2 | 2018 | 461 | 0.170 |
Why?
|
Transcription Factor AP-1 | 1 | 2020 | 317 | 0.170 |
Why?
|
Quinazolines | 3 | 2018 | 1356 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2021 | 2504 | 0.170 |
Why?
|
HCT116 Cells | 3 | 2016 | 409 | 0.170 |
Why?
|
Doxorubicin | 3 | 2018 | 2234 | 0.160 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2015 | 4386 | 0.160 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2021 | 520 | 0.160 |
Why?
|
Pyrroles | 3 | 2012 | 1147 | 0.160 |
Why?
|
DNA Fingerprinting | 1 | 2018 | 112 | 0.160 |
Why?
|
Epoxy Compounds | 1 | 2018 | 136 | 0.160 |
Why?
|
Mitochondrial Membrane Transport Proteins | 2 | 2016 | 154 | 0.160 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2021 | 1861 | 0.160 |
Why?
|
Structure-Activity Relationship | 6 | 2017 | 3128 | 0.150 |
Why?
|
Genomics | 7 | 2021 | 5714 | 0.150 |
Why?
|
Leiomyosarcoma | 1 | 2022 | 477 | 0.150 |
Why?
|
Drug Combinations | 1 | 2023 | 1958 | 0.150 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2014 | 4477 | 0.150 |
Why?
|
Protein Structure, Tertiary | 4 | 2014 | 3847 | 0.150 |
Why?
|
Dimerization | 2 | 2010 | 894 | 0.150 |
Why?
|
Biomimetic Materials | 2 | 2017 | 179 | 0.150 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3583 | 0.150 |
Why?
|
RNA Stability | 1 | 2019 | 320 | 0.150 |
Why?
|
Histone Demethylases | 1 | 2020 | 321 | 0.150 |
Why?
|
Immunophenotyping | 1 | 2022 | 1880 | 0.150 |
Why?
|
Macrolides | 1 | 2018 | 201 | 0.150 |
Why?
|
Phagocytosis | 2 | 2017 | 1539 | 0.150 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2022 | 1335 | 0.150 |
Why?
|
Graft vs Host Disease | 2 | 2024 | 2958 | 0.150 |
Why?
|
Thiazoles | 2 | 2021 | 1482 | 0.150 |
Why?
|
Aneuploidy | 1 | 2020 | 530 | 0.150 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2017 | 2453 | 0.150 |
Why?
|
Oxadiazoles | 1 | 2017 | 93 | 0.150 |
Why?
|
Dendritic Cells | 2 | 2019 | 2720 | 0.150 |
Why?
|
Receptors, Notch | 1 | 2021 | 739 | 0.140 |
Why?
|
Gene Expression Profiling | 5 | 2016 | 9440 | 0.140 |
Why?
|
Urothelium | 1 | 2019 | 277 | 0.140 |
Why?
|
Enzyme Inhibitors | 2 | 2018 | 3794 | 0.140 |
Why?
|
Peptide Library | 2 | 2016 | 349 | 0.140 |
Why?
|
Molecular Sequence Data | 9 | 2014 | 18107 | 0.140 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2021 | 571 | 0.140 |
Why?
|
Intermediate Filaments | 4 | 1995 | 175 | 0.140 |
Why?
|
Wilms Tumor | 1 | 2019 | 373 | 0.140 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2017 | 150 | 0.140 |
Why?
|
Pyrazines | 2 | 2017 | 1230 | 0.140 |
Why?
|
Gene Expression | 5 | 2022 | 7793 | 0.140 |
Why?
|
Lymphoma, T-Cell | 1 | 2018 | 299 | 0.140 |
Why?
|
Cytoplasm | 2 | 2018 | 1536 | 0.140 |
Why?
|
Pyrazoles | 2 | 2017 | 1970 | 0.140 |
Why?
|
Genes, myc | 2 | 2009 | 399 | 0.140 |
Why?
|
Myofibroblasts | 1 | 2017 | 222 | 0.130 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2021 | 5445 | 0.130 |
Why?
|
Thrombocytopenia | 2 | 2020 | 1178 | 0.130 |
Why?
|
Disease-Free Survival | 3 | 2018 | 6895 | 0.130 |
Why?
|
Tissue Banks | 1 | 2016 | 184 | 0.130 |
Why?
|
Immunoblotting | 2 | 2010 | 1683 | 0.130 |
Why?
|
Tissue Fixation | 1 | 2016 | 241 | 0.130 |
Why?
|
Ubiquitin | 3 | 2017 | 851 | 0.130 |
Why?
|
Lymphoma | 3 | 2016 | 1875 | 0.130 |
Why?
|
Protein Structure, Secondary | 2 | 2016 | 1245 | 0.130 |
Why?
|
Aged, 80 and over | 10 | 2020 | 57744 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2022 | 9239 | 0.130 |
Why?
|
RNA, Small Interfering | 4 | 2019 | 3504 | 0.120 |
Why?
|
Remission Induction | 3 | 2020 | 2384 | 0.120 |
Why?
|
Myocardial Ischemia | 1 | 2005 | 2150 | 0.120 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2019 | 388 | 0.120 |
Why?
|
Principal Component Analysis | 1 | 2017 | 935 | 0.120 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2017 | 449 | 0.120 |
Why?
|
Neoplasm Transplantation | 4 | 2021 | 2085 | 0.120 |
Why?
|
Topoisomerase Inhibitors | 1 | 2013 | 18 | 0.120 |
Why?
|
Macrophage Activation | 1 | 2017 | 559 | 0.120 |
Why?
|
Thalidomide | 1 | 2019 | 890 | 0.120 |
Why?
|
Phosphorylation | 5 | 2018 | 8436 | 0.120 |
Why?
|
Digitonin | 1 | 2013 | 27 | 0.120 |
Why?
|
Sequence Deletion | 1 | 2018 | 1524 | 0.120 |
Why?
|
Hydrazines | 1 | 2015 | 225 | 0.120 |
Why?
|
Leukemia, Myeloid | 1 | 2017 | 707 | 0.120 |
Why?
|
HeLa Cells | 3 | 2016 | 3130 | 0.120 |
Why?
|
Disease Outbreaks | 1 | 2003 | 1771 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 3 | 2019 | 2850 | 0.110 |
Why?
|
Single-Cell Analysis | 3 | 2023 | 2177 | 0.110 |
Why?
|
Administration, Oral | 3 | 2018 | 3912 | 0.110 |
Why?
|
Male | 26 | 2021 | 349776 | 0.110 |
Why?
|
Immunoconjugates | 1 | 2020 | 901 | 0.110 |
Why?
|
Fluorometry | 1 | 2013 | 106 | 0.110 |
Why?
|
Alternative Splicing | 1 | 2018 | 1117 | 0.110 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2015 | 294 | 0.110 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 197 | 0.110 |
Why?
|
Cell Division | 1 | 2020 | 4568 | 0.110 |
Why?
|
Treatment Outcome | 9 | 2019 | 63042 | 0.110 |
Why?
|
Base Sequence | 5 | 2019 | 12798 | 0.110 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2015 | 233 | 0.110 |
Why?
|
Mice, Nude | 5 | 2019 | 3680 | 0.110 |
Why?
|
Purines | 2 | 2014 | 590 | 0.110 |
Why?
|
Topoisomerase II Inhibitors | 1 | 2012 | 87 | 0.110 |
Why?
|
Thromboembolism | 1 | 1999 | 987 | 0.100 |
Why?
|
Aged | 12 | 2020 | 163178 | 0.100 |
Why?
|
Indoles | 2 | 2012 | 1841 | 0.100 |
Why?
|
Biological Assay | 1 | 2015 | 650 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2014 | 2938 | 0.100 |
Why?
|
Survival Analysis | 4 | 2018 | 10251 | 0.100 |
Why?
|
Staining and Labeling | 1 | 2016 | 1098 | 0.100 |
Why?
|
Mice, Transgenic | 6 | 2021 | 9731 | 0.100 |
Why?
|
Plasma Cells | 1 | 2015 | 593 | 0.100 |
Why?
|
Herpesvirus 4, Human | 1 | 2017 | 1041 | 0.100 |
Why?
|
Genes, p53 | 3 | 2020 | 755 | 0.100 |
Why?
|
RNA Interference | 4 | 2019 | 2890 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4931 | 0.100 |
Why?
|
Aminopyridines | 1 | 2015 | 543 | 0.100 |
Why?
|
Vincristine | 2 | 2018 | 1039 | 0.100 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2016 | 501 | 0.100 |
Why?
|
Brain Ischemia | 1 | 2005 | 3264 | 0.100 |
Why?
|
B-Lymphocytes | 3 | 2019 | 4665 | 0.100 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2012 | 349 | 0.100 |
Why?
|
Anemia | 1 | 2020 | 1502 | 0.100 |
Why?
|
Tumor Burden | 1 | 2017 | 1917 | 0.100 |
Why?
|
Quinazolinones | 1 | 2012 | 221 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 602 | 0.090 |
Why?
|
Interleukins | 1 | 2015 | 791 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 489 | 0.090 |
Why?
|
Glioblastoma | 2 | 2017 | 3480 | 0.090 |
Why?
|
Mutagenesis, Site-Directed | 2 | 1993 | 1723 | 0.090 |
Why?
|
Endoribonucleases | 1 | 2012 | 229 | 0.090 |
Why?
|
Chemokine CXCL12 | 1 | 2012 | 465 | 0.090 |
Why?
|
Cross-Priming | 1 | 2010 | 82 | 0.090 |
Why?
|
Unfolded Protein Response | 1 | 2012 | 233 | 0.090 |
Why?
|
Benzimidazoles | 1 | 2015 | 850 | 0.090 |
Why?
|
Protein Kinases | 1 | 2017 | 1640 | 0.090 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 689 | 0.090 |
Why?
|
Sarcoma | 1 | 2021 | 1898 | 0.090 |
Why?
|
Triazoles | 1 | 2015 | 904 | 0.090 |
Why?
|
Metabolomics | 1 | 2018 | 1487 | 0.090 |
Why?
|
Hydrogen Peroxide | 1 | 2013 | 730 | 0.090 |
Why?
|
Ubiquitination | 1 | 2014 | 1011 | 0.090 |
Why?
|
P-Selectin | 1 | 2011 | 601 | 0.080 |
Why?
|
Survival Rate | 3 | 2021 | 12786 | 0.080 |
Why?
|
Tumor Stem Cell Assay | 1 | 2008 | 118 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 2217 | 0.080 |
Why?
|
Multigene Family | 2 | 2010 | 1101 | 0.080 |
Why?
|
Neutrophils | 1 | 2021 | 3718 | 0.080 |
Why?
|
Coculture Techniques | 1 | 2012 | 1342 | 0.080 |
Why?
|
Half-Life | 1 | 2009 | 660 | 0.080 |
Why?
|
Mice, Inbred C57BL | 6 | 2018 | 21824 | 0.080 |
Why?
|
DNA Repair | 1 | 2018 | 2045 | 0.080 |
Why?
|
Cell Lineage | 3 | 2016 | 2506 | 0.080 |
Why?
|
Transplantation, Homologous | 4 | 2024 | 4777 | 0.080 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 1585 | 0.080 |
Why?
|
Host-Pathogen Interactions | 1 | 2017 | 1479 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2019 | 3024 | 0.080 |
Why?
|
Dexamethasone | 1 | 2015 | 1950 | 0.080 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2022 | 539 | 0.080 |
Why?
|
Recurrence | 2 | 2020 | 8337 | 0.080 |
Why?
|
Annexin A5 | 1 | 2007 | 103 | 0.080 |
Why?
|
Chromatography, Affinity | 1 | 1988 | 549 | 0.080 |
Why?
|
Autophagy | 1 | 2015 | 1296 | 0.080 |
Why?
|
Bone Marrow Cells | 2 | 2012 | 2509 | 0.080 |
Why?
|
Caspase 9 | 1 | 2007 | 188 | 0.080 |
Why?
|
Point Mutation | 1 | 1993 | 1623 | 0.080 |
Why?
|
Electron Transport Complex IV | 1 | 2007 | 189 | 0.080 |
Why?
|
Immunoglobulin M | 1 | 2012 | 1537 | 0.080 |
Why?
|
Binding, Competitive | 1 | 2008 | 1157 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 4749 | 0.070 |
Why?
|
Middle Aged | 10 | 2020 | 213241 | 0.070 |
Why?
|
Transcriptional Activation | 1 | 2013 | 1783 | 0.070 |
Why?
|
Cells, Cultured | 8 | 2018 | 19232 | 0.070 |
Why?
|
HEK293 Cells | 3 | 2021 | 4204 | 0.070 |
Why?
|
Proteomics | 4 | 2023 | 3639 | 0.070 |
Why?
|
Enzyme Activators | 1 | 2006 | 57 | 0.070 |
Why?
|
Sulfones | 1 | 2008 | 434 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2019 | 2248 | 0.070 |
Why?
|
Up-Regulation | 2 | 2018 | 4221 | 0.070 |
Why?
|
Clone Cells | 2 | 2021 | 1692 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2015 | 1580 | 0.070 |
Why?
|
Fibroblasts | 1 | 2016 | 4162 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2013 | 11036 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2013 | 1295 | 0.070 |
Why?
|
Radiation Tolerance | 1 | 2008 | 486 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4251 | 0.070 |
Why?
|
Glucose | 1 | 2017 | 4398 | 0.060 |
Why?
|
Wnt Proteins | 1 | 2009 | 721 | 0.060 |
Why?
|
Blotting, Western | 2 | 2017 | 5179 | 0.060 |
Why?
|
Gene Dosage | 1 | 2010 | 1252 | 0.060 |
Why?
|
Nucleic Acid Conformation | 1 | 1988 | 914 | 0.060 |
Why?
|
Intracellular Membranes | 1 | 2006 | 391 | 0.060 |
Why?
|
Fluorescent Dyes | 1 | 2013 | 1903 | 0.060 |
Why?
|
Mesothelioma | 1 | 2011 | 818 | 0.060 |
Why?
|
Interleukin-3 | 1 | 2006 | 444 | 0.060 |
Why?
|
T-Lymphocytes | 4 | 2023 | 10179 | 0.060 |
Why?
|
Adult | 9 | 2023 | 213889 | 0.060 |
Why?
|
Glycosylation | 1 | 2008 | 1129 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2017 | 8856 | 0.060 |
Why?
|
Serine | 1 | 2008 | 825 | 0.060 |
Why?
|
Leukemia, B-Cell | 1 | 2004 | 86 | 0.060 |
Why?
|
Keratinocytes | 3 | 1993 | 796 | 0.060 |
Why?
|
Prognosis | 3 | 2021 | 29052 | 0.060 |
Why?
|
beta Catenin | 1 | 2009 | 1060 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4569 | 0.060 |
Why?
|
Phenotype | 4 | 2017 | 16361 | 0.060 |
Why?
|
Cisplatin | 2 | 2020 | 1662 | 0.060 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2008 | 2839 | 0.060 |
Why?
|
Anticoagulants | 1 | 1999 | 4599 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39001 | 0.060 |
Why?
|
Genome, Human | 1 | 2016 | 4418 | 0.060 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2007 | 690 | 0.060 |
Why?
|
Age Factors | 2 | 2018 | 18355 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 3255 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3591 | 0.060 |
Why?
|
Lactones | 1 | 2005 | 329 | 0.060 |
Why?
|
Doxycycline | 1 | 2004 | 326 | 0.050 |
Why?
|
Cytochrome c Group | 1 | 2002 | 128 | 0.050 |
Why?
|
Crystallography, X-Ray | 2 | 2018 | 2011 | 0.050 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2005 | 506 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4260 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2018 | 4033 | 0.050 |
Why?
|
Cell Differentiation | 4 | 2017 | 11478 | 0.050 |
Why?
|
Molecular Mimicry | 1 | 2003 | 201 | 0.050 |
Why?
|
Stress, Physiological | 1 | 2010 | 1403 | 0.050 |
Why?
|
Janus Kinase 3 | 1 | 2022 | 78 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2018 | 10940 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2005 | 792 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9648 | 0.050 |
Why?
|
Transplantation, Isogeneic | 1 | 2021 | 257 | 0.050 |
Why?
|
Transfection | 3 | 2016 | 5892 | 0.050 |
Why?
|
DNA Copy Number Variations | 1 | 2010 | 1937 | 0.050 |
Why?
|
Daptomycin | 1 | 2021 | 73 | 0.050 |
Why?
|
Protein Interaction Mapping | 2 | 2018 | 626 | 0.050 |
Why?
|
Bone Marrow | 1 | 2011 | 2951 | 0.050 |
Why?
|
Naphthoquinones | 1 | 2021 | 77 | 0.050 |
Why?
|
Adenine | 2 | 2017 | 935 | 0.050 |
Why?
|
Boronic Acids | 1 | 2005 | 965 | 0.050 |
Why?
|
Clinical Trials as Topic | 3 | 2017 | 7908 | 0.050 |
Why?
|
Busulfan | 1 | 2021 | 263 | 0.050 |
Why?
|
Ikaros Transcription Factor | 1 | 2022 | 217 | 0.050 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 98 | 0.050 |
Why?
|
Jurkat Cells | 1 | 2002 | 743 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2012 | 3476 | 0.050 |
Why?
|
Benzofurans | 1 | 2021 | 140 | 0.050 |
Why?
|
Central Nervous System | 1 | 2008 | 1358 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2011 | 3769 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2014 | 2988 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2018 | 6363 | 0.050 |
Why?
|
Genes, cdc | 1 | 2020 | 116 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2021 | 323 | 0.050 |
Why?
|
Vidarabine | 1 | 2021 | 345 | 0.050 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1678 | 0.050 |
Why?
|
History, 21st Century | 1 | 2006 | 1532 | 0.050 |
Why?
|
Leukopenia | 1 | 2020 | 213 | 0.040 |
Why?
|
Tristetraprolin | 1 | 2019 | 42 | 0.040 |
Why?
|
Disease Progression | 4 | 2019 | 13273 | 0.040 |
Why?
|
Amino Acid Substitution | 2 | 2014 | 1793 | 0.040 |
Why?
|
Trisomy | 1 | 2020 | 265 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2022 | 323 | 0.040 |
Why?
|
Transduction, Genetic | 1 | 2002 | 913 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 426 | 0.040 |
Why?
|
Cohort Studies | 2 | 2019 | 40545 | 0.040 |
Why?
|
Models, Molecular | 3 | 2017 | 5445 | 0.040 |
Why?
|
Macrocyclic Compounds | 1 | 2018 | 72 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6539 | 0.040 |
Why?
|
History, 20th Century | 1 | 2006 | 2736 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2016 | 2556 | 0.040 |
Why?
|
Spliceosomes | 1 | 2018 | 110 | 0.040 |
Why?
|
Piperidines | 2 | 2017 | 1601 | 0.040 |
Why?
|
Drug Discovery | 2 | 2016 | 1058 | 0.040 |
Why?
|
Transcription Factors | 3 | 2023 | 12209 | 0.040 |
Why?
|
Germinal Center | 1 | 2021 | 377 | 0.040 |
Why?
|
Neuroblastoma | 1 | 2006 | 1226 | 0.040 |
Why?
|
Cell Cycle | 2 | 2020 | 2963 | 0.040 |
Why?
|
Circular Dichroism | 1 | 2018 | 353 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2019 | 553 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2019 | 712 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 480 | 0.040 |
Why?
|
Research Personnel | 1 | 2022 | 573 | 0.040 |
Why?
|
Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2016 | 24 | 0.040 |
Why?
|
HMGA2 Protein | 1 | 2017 | 123 | 0.040 |
Why?
|
Transplantation Conditioning | 1 | 2024 | 1599 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 1 | 2022 | 1142 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 407 | 0.040 |
Why?
|
Zebrafish | 1 | 2008 | 2995 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2021 | 808 | 0.040 |
Why?
|
Cell-Free System | 1 | 2016 | 344 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2021 | 1729 | 0.030 |
Why?
|
Graphite | 1 | 2016 | 66 | 0.030 |
Why?
|
Dermis | 1 | 2017 | 207 | 0.030 |
Why?
|
Cell Membrane | 1 | 2006 | 3749 | 0.030 |
Why?
|
Histiocytic Sarcoma | 1 | 2016 | 44 | 0.030 |
Why?
|
Receptors, Interleukin-21 | 1 | 2015 | 33 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 2016 | 246 | 0.030 |
Why?
|
Pathology | 1 | 2019 | 272 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2016 | 223 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2017 | 261 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1038 | 0.030 |
Why?
|
Transplantation, Heterologous | 2 | 2017 | 2378 | 0.030 |
Why?
|
Spectrometry, Fluorescence | 1 | 2018 | 688 | 0.030 |
Why?
|
RNA, Messenger | 4 | 2019 | 13028 | 0.030 |
Why?
|
Parkinson Disease | 1 | 2009 | 2785 | 0.030 |
Why?
|
Protein Conformation | 2 | 2014 | 4009 | 0.030 |
Why?
|
Hyperkeratosis, Epidermolytic | 1 | 1994 | 7 | 0.030 |
Why?
|
Cell Transdifferentiation | 1 | 2016 | 172 | 0.030 |
Why?
|
Time Factors | 4 | 2018 | 40038 | 0.030 |
Why?
|
Mutation, Missense | 2 | 2014 | 2566 | 0.030 |
Why?
|
Calorimetry | 1 | 1995 | 126 | 0.030 |
Why?
|
Cyclin D1 | 1 | 2017 | 463 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2019 | 1802 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2017 | 575 | 0.030 |
Why?
|
Metalloendopeptidases | 1 | 2016 | 396 | 0.030 |
Why?
|
Cytoprotection | 1 | 2015 | 209 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 12066 | 0.030 |
Why?
|
Gene Products, tax | 1 | 2014 | 51 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2019 | 1284 | 0.030 |
Why?
|
Isoquinolines | 1 | 2016 | 364 | 0.030 |
Why?
|
Antimitotic Agents | 1 | 2014 | 29 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2016 | 684 | 0.030 |
Why?
|
Fluorescence Polarization | 1 | 2014 | 132 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2023 | 2419 | 0.030 |
Why?
|
Proteome | 2 | 2016 | 1794 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2009 | 0.030 |
Why?
|
HTLV-I Infections | 1 | 2014 | 101 | 0.030 |
Why?
|
Scleroderma, Systemic | 1 | 2017 | 323 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2021 | 14563 | 0.030 |
Why?
|
Prednisone | 1 | 2018 | 1574 | 0.030 |
Why?
|
Teratoma | 1 | 2016 | 393 | 0.030 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2014 | 140 | 0.030 |
Why?
|
Caspase 8 | 1 | 2014 | 195 | 0.030 |
Why?
|
Threonine | 1 | 2014 | 279 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 381 | 0.030 |
Why?
|
Nephrectomy | 1 | 2019 | 1048 | 0.030 |
Why?
|
Cell Nucleus | 2 | 2013 | 2969 | 0.030 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2014 | 166 | 0.030 |
Why?
|
GTP Phosphohydrolases | 1 | 2016 | 508 | 0.030 |
Why?
|
Disease | 1 | 2019 | 680 | 0.030 |
Why?
|
Ichthyosiform Erythroderma, Congenital | 1 | 1992 | 7 | 0.030 |
Why?
|
Molecular Structure | 1 | 2017 | 1894 | 0.030 |
Why?
|
Methylnitronitrosoguanidine | 1 | 2012 | 20 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1104 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2274 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2018 | 2241 | 0.030 |
Why?
|
Chickens | 1 | 1995 | 864 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2022 | 2107 | 0.030 |
Why?
|
Mechanotransduction, Cellular | 1 | 2017 | 541 | 0.030 |
Why?
|
Plasmids | 1 | 2017 | 2308 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2017 | 2725 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2018 | 2971 | 0.030 |
Why?
|
Caspase 3 | 1 | 2014 | 758 | 0.030 |
Why?
|
Breast | 1 | 2020 | 1970 | 0.020 |
Why?
|
Nanostructures | 1 | 2016 | 552 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2015 | 671 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2429 | 0.020 |
Why?
|
Child | 3 | 2019 | 77637 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2013 | 443 | 0.020 |
Why?
|
Conserved Sequence | 1 | 1995 | 1202 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2016 | 914 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2015 | 873 | 0.020 |
Why?
|
Glycolipids | 1 | 2011 | 204 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3772 | 0.020 |
Why?
|
Blood Cells | 1 | 2013 | 310 | 0.020 |
Why?
|
Fibrosis | 1 | 2017 | 2030 | 0.020 |
Why?
|
Acrylamides | 1 | 2012 | 255 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2931 | 0.020 |
Why?
|
Testicular Neoplasms | 1 | 2016 | 803 | 0.020 |
Why?
|
Biosensing Techniques | 1 | 2016 | 667 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2203 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2018 | 1372 | 0.020 |
Why?
|
Proline | 1 | 1992 | 457 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 56392 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1743 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2019 | 2039 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 1995 | 1254 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2018 | 2440 | 0.020 |
Why?
|
Polyribonucleotides | 1 | 1988 | 5 | 0.020 |
Why?
|
Pyridines | 1 | 2021 | 2827 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2796 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1691 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 21733 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2021 | 3587 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2012 | 807 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2002 | 5021 | 0.020 |
Why?
|
Binding Sites | 1 | 2018 | 6111 | 0.020 |
Why?
|
Mitosis | 1 | 2014 | 1207 | 0.020 |
Why?
|
Sepharose | 1 | 1988 | 108 | 0.020 |
Why?
|
Base Composition | 1 | 1988 | 293 | 0.020 |
Why?
|
Amino Acids | 1 | 1995 | 1733 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2133 | 0.020 |
Why?
|
Hydrogen Bonding | 1 | 1988 | 291 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2019 | 2899 | 0.020 |
Why?
|
Pancreas Transplantation | 1 | 1989 | 187 | 0.020 |
Why?
|
Homeostasis | 1 | 2019 | 3337 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2014 | 3701 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2016 | 1940 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6188 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2013 | 1374 | 0.020 |
Why?
|
Guinea Pigs | 1 | 2009 | 1386 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1537 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2727 | 0.020 |
Why?
|
Biological Evolution | 1 | 1993 | 1079 | 0.020 |
Why?
|
DNA, Single-Stranded | 1 | 1988 | 354 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3089 | 0.020 |
Why?
|
Cell Movement | 2 | 2011 | 5216 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12020 | 0.020 |
Why?
|
Acute Disease | 1 | 2017 | 7150 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4803 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6750 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2016 | 4848 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1962 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4286 | 0.020 |
Why?
|
Gene Amplification | 1 | 2010 | 1063 | 0.020 |
Why?
|
Plasmacytoma | 1 | 2005 | 183 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2011 | 3144 | 0.020 |
Why?
|
Tissue Donors | 1 | 2014 | 2241 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2009 | 1213 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7719 | 0.020 |
Why?
|
Attachment Sites, Microbiological | 1 | 2003 | 26 | 0.020 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1989 | 1475 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2942 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3058 | 0.010 |
Why?
|
Kidney | 1 | 2019 | 7185 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2014 | 2750 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7172 | 0.010 |
Why?
|
Carcinoma, Small Cell | 1 | 2005 | 420 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2012 | 2418 | 0.010 |
Why?
|
Integrases | 1 | 2003 | 533 | 0.010 |
Why?
|
Antigens, CD19 | 1 | 2003 | 380 | 0.010 |
Why?
|
Rats | 2 | 1995 | 24250 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 5983 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 9944 | 0.010 |
Why?
|
Chronic Disease | 1 | 2014 | 9139 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2013 | 5854 | 0.010 |
Why?
|
Spleen | 1 | 2003 | 2359 | 0.010 |
Why?
|
Infant | 1 | 2019 | 35122 | 0.010 |
Why?
|
NF-kappa B | 1 | 2005 | 2500 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 40964 | 0.010 |
Why?
|
Gene Deletion | 1 | 2003 | 2749 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2005 | 3758 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 53250 | 0.010 |
Why?
|
Alleles | 1 | 2003 | 6934 | 0.010 |
Why?
|
Epidermis | 1 | 1994 | 529 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 85729 | 0.010 |
Why?
|
Stem Cells | 1 | 2003 | 3566 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2018 | 77410 | 0.010 |
Why?
|
Cytokines | 1 | 2003 | 7324 | 0.010 |
Why?
|
Oligonucleotides | 1 | 1991 | 572 | 0.000 |
Why?
|
Rats, Inbred Lew | 1 | 1989 | 1162 | 0.000 |
Why?
|
Genetic Engineering | 1 | 1992 | 950 | 0.000 |
Why?
|
Perfusion | 1 | 1989 | 1359 | 0.000 |
Why?
|
DNA Mutational Analysis | 1 | 1991 | 4183 | 0.000 |
Why?
|
Islets of Langerhans | 1 | 1989 | 1350 | 0.000 |
Why?
|
Pancreas | 1 | 1989 | 1686 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1991 | 6620 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1989 | 9272 | 0.000 |
Why?
|